Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
17,300
-
Share change
-
-31,376,092
-
Total reported value
-
$2,981,708
-
Price per share
-
$172.36
-
Number of holders
-
2
-
Value change
-
-$3,198,726,480
-
Number of sells
-
204
Institutional Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q3 2023
As of 30 Sep 2023,
REATA PHARMACEUTICALS INC - CL A (RETA) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,300 shares.
The largest 2 holders included
DekaBank Deutsche Girozentrale and IFP Advisors, Inc.
This page lists
2
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.